$141 Million is the total value of First Light Asset Management, LLC's 70 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 39.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATRC | Sell | ATRICURE INCcs | $8,647,000 | -22.7% | 459,709 | -23.3% | 6.12% | -35.4% |
| SPNC | Buy | SPECTRANETICScs | $8,212,000 | +38.0% | 270,934 | +13.8% | 5.82% | +15.3% |
| IG | New | IGI LABS INCcs | $6,406,000 | – | 1,133,778 | +100.0% | 4.54% | – |
| NEO | Buy | NEOGENOMICS INcs | $5,098,000 | +28.5% | 1,469,078 | +34.1% | 3.61% | +7.4% |
| RTIX | Sell | RTI SURGICAL Ics | $5,057,000 | +1.7% | 1,239,460 | -11.8% | 3.58% | -15.1% |
| LGND | Buy | LIGAND PHARMACcs | $4,720,000 | +48.9% | 70,162 | +16.5% | 3.34% | +24.5% |
| ARRY | Buy | ARRAY BIOPHARMcs | $4,591,000 | +6.5% | 976,799 | +13.6% | 3.25% | -11.0% |
| HBIO | New | HARVARD BIOSCIcs | $4,557,000 | – | 961,497 | +100.0% | 3.23% | – |
| ENZ | New | ENZO BIOCHEM Ics | $4,383,000 | – | 1,053,702 | +100.0% | 3.10% | – |
| QDEL | Buy | QUIDEL CORPcs | $4,359,000 | +0.1% | 159,662 | +13.2% | 3.09% | -16.4% |
| AKRXQ | New | AKORN INCcs | $4,355,000 | – | 197,956 | +100.0% | 3.08% | – |
| NVDQ | Buy | NOVADAQ TECHNOcs | $4,310,000 | +53.7% | 193,450 | +13.7% | 3.05% | +28.4% |
| OMCL | Buy | OMNICELL INCcs | $4,093,000 | +28.8% | 142,998 | +14.9% | 2.90% | +7.6% |
| STRM | Buy | STREAMLINE HEAcs | $3,821,000 | +11.6% | 759,634 | +54.8% | 2.71% | -6.8% |
| STAA | Buy | STAAR SURGICALcs | $3,626,000 | +36.5% | 192,887 | +17.6% | 2.57% | +14.1% |
| LCI | Sell | LANNET INCcs | $3,578,000 | -23.1% | 100,157 | -28.7% | 2.54% | -35.7% |
| OXFD | New | OXFORD IMMUNOTcs | $3,519,000 | – | 175,347 | +100.0% | 2.49% | – |
| STKL | Sell | SUNOPTA INCcs | $3,059,000 | -16.8% | 258,986 | -29.5% | 2.17% | -30.5% |
| FLDM | Buy | FLUIDIGM CORPcs | $3,015,000 | +35.4% | 68,415 | +17.6% | 2.14% | +13.1% |
| TECH | New | TECHNE CORPcs | $2,896,000 | – | 33,926 | +100.0% | 2.05% | – |
| SPPI | New | SPECTRUM PHARMcs | $2,738,000 | – | 349,267 | +100.0% | 1.94% | – |
| CPHD | Buy | CEPHEIDcs | $2,689,000 | +28.5% | 52,127 | +16.2% | 1.90% | +7.3% |
| ALKS | Buy | ALKERMES PLCcs | $2,657,000 | +27.6% | 60,255 | +17.6% | 1.88% | +6.6% |
| P103PS | Buy | NPS PHARMACEUTcs | $2,367,000 | +14.2% | 79,099 | +15.9% | 1.68% | -4.6% |
| CLDX | Buy | CELLDEX THERAPcs | $2,342,000 | -16.7% | 132,548 | +14.2% | 1.66% | -30.4% |
| NXTM | New | NXSTAGE MEDICAcs | $2,238,000 | – | 175,655 | +100.0% | 1.58% | – |
| ABCO | Buy | ADVISORY BRD Ccs | $2,141,000 | +17.8% | 33,327 | +16.7% | 1.52% | -1.6% |
| HSTM | Buy | HEALTHSTREAM Ics | $1,866,000 | -4.4% | 69,891 | +16.8% | 1.32% | -20.1% |
| LMAT | Buy | LEMAITRE VASCUcs | $1,803,000 | +18.9% | 223,409 | +18.0% | 1.28% | -0.7% |
| ALGN | New | ALIGN TECHNOLOcs | $1,623,000 | – | 31,346 | +100.0% | 1.15% | – |
| SGNT | Buy | SAGENT PHARMACcs | $1,516,000 | +7.4% | 64,856 | +16.6% | 1.07% | -10.3% |
| CYTK | Buy | CYTOKINETICS Ics | $1,457,000 | +71.8% | 153,338 | +17.5% | 1.03% | +43.5% |
| MASI | Buy | MASIMO CORPcs | $1,416,000 | +8.5% | 51,865 | +16.2% | 1.00% | -9.3% |
| GNMK | Buy | GENMARK DIAGNOcs | $1,403,000 | -10.8% | 141,124 | +19.3% | 0.99% | -25.5% |
| BMRN | Buy | BIOMARIN PHARMcs | $1,275,000 | +11.7% | 18,689 | +15.2% | 0.90% | -6.6% |
| OREX | Buy | OREXIGEN THERAcs | $1,270,000 | +32.0% | 195,359 | +14.4% | 0.90% | +10.3% |
| F113PS | Buy | COVIDIEN PLCcs | $1,253,000 | +26.2% | 17,013 | +16.7% | 0.89% | +5.5% |
| ELGX | Buy | ENDOLOGIX INCcs | $1,129,000 | -14.5% | 87,758 | +15.9% | 0.80% | -28.6% |
| VRTX | Buy | VERTEX PHARMACcs | $1,060,000 | +9.6% | 14,990 | +15.1% | 0.75% | -8.4% |
| ANGO | Buy | ANGIODYNAMICScs | $1,012,000 | +3.7% | 64,260 | +13.0% | 0.72% | -13.3% |
| HTWR | Buy | HEARTWARE INTLcs | $986,000 | +17.0% | 10,516 | +17.1% | 0.70% | -2.4% |
| PETX | Sell | ARATANA THERAPcs | $914,000 | -11.9% | 49,263 | -9.3% | 0.65% | -26.4% |
| THOR | Buy | THORATEC CORPcs | $867,000 | +10.2% | 24,204 | +12.5% | 0.61% | -7.9% |
| SURG | Buy | SYNERGETICS UScs | $832,000 | -2.2% | 272,851 | +16.1% | 0.59% | -18.4% |
| FRX | FOREST LABS INcs | $704,000 | +53.7% | 7,635 | 0.0% | 0.50% | +28.6% | |
| VVUS | Buy | VIVUS INCcs | $693,000 | -21.9% | 116,696 | +19.5% | 0.49% | -34.7% |
| ENDP | New | ENDO INTL PLCcs | $626,000 | – | 9,125 | +100.0% | 0.44% | – |
| NVS | NOVARTIS A Gadr | $516,000 | +5.7% | 6,070 | 0.0% | 0.37% | -11.6% | |
| MYL | MYLAN INCcs | $477,000 | +12.5% | 9,775 | 0.0% | 0.34% | -5.8% | |
| BMY | BRISTOL MYERScs | $431,000 | -2.3% | 8,290 | 0.0% | 0.30% | -18.4% | |
| V107SC | WELLPOINT INCcs | $408,000 | +7.9% | 4,095 | 0.0% | 0.29% | -9.7% | |
| HUM | HUMANA INCcs | $399,000 | +9.3% | 3,540 | 0.0% | 0.28% | -8.4% | |
| STJ | ST JUDE MED INcs | $396,000 | +5.6% | 6,055 | 0.0% | 0.28% | -11.6% | |
| AET | AETNA INC NEWcs | $391,000 | +9.2% | 5,215 | 0.0% | 0.28% | -8.9% | |
| JNJ | JOHNSON & JOHNcs | $375,000 | +7.1% | 3,820 | 0.0% | 0.27% | -10.4% | |
| MRK | MERCK & CO INCcs | $375,000 | +13.3% | 6,610 | 0.0% | 0.27% | -5.3% | |
| AZN | New | ASTRAZENECA PLadr | $369,000 | – | 5,680 | +100.0% | 0.26% | – |
| UTHR | UNITED THERAPEcs | $359,000 | -16.9% | 3,820 | 0.0% | 0.25% | -30.6% | |
| PFE | PFIZER INCcs | $338,000 | +5.0% | 10,520 | 0.0% | 0.24% | -12.5% | |
| BDX | New | BECTON DICKINScs | $327,000 | – | 2,795 | +100.0% | 0.23% | – |
| LLY | LILLY ELI & COcs | $323,000 | +15.4% | 5,495 | 0.0% | 0.23% | -3.4% | |
| CFN | CAREFUSION CORcs | $311,000 | +1.0% | 7,730 | 0.0% | 0.22% | -15.7% | |
| STE | STERIS CORPcs | $302,000 | -0.7% | 6,330 | 0.0% | 0.21% | -17.1% | |
| CELG | CELGENE CORPcs | $299,000 | -17.4% | 2,140 | 0.0% | 0.21% | -30.9% | |
| SNY | SANOFIadr | $297,000 | -2.6% | 5,680 | 0.0% | 0.21% | -18.9% | |
| AMGN | New | AMGEN INCcs | $287,000 | – | 2,330 | +100.0% | 0.20% | – |
| A | AGILENT TECHNOcs | $286,000 | -2.4% | 5,120 | 0.0% | 0.20% | -18.1% | |
| MYGN | New | MYRIAD GENETICcs | $267,000 | – | 7,820 | +100.0% | 0.19% | – |
| CYH | COMMUNITY HEALcs | $241,000 | 0.0% | 6,145 | 0.0% | 0.17% | -16.2% | |
| BIO | New | BIO RAD LABS Ics | $215,000 | – | 1,675 | +100.0% | 0.15% | – |
| Exit | BIO RAD LABS INCcl a | $0 | – | -1,675 | -100.0% | -0.18% | – | |
| Exit | AMGEN INC | $0 | – | -2,330 | -100.0% | -0.23% | – | |
| Exit | BECTON DICKINSON & CO | $0 | – | -2,795 | -100.0% | -0.26% | – | |
| Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -5,680 | -100.0% | -0.29% | – | |
| ENDP | Exit | ENDO HEALTH SOLUTIONS INC | $0 | – | -9,125 | -100.0% | -0.52% | – |
| Exit | ALIGN TECHNOLOGY INC | $0 | – | -27,110 | -100.0% | -1.31% | – | |
| Exit | ARTHROCARE CORP | $0 | – | -44,010 | -100.0% | -1.50% | – | |
| ACCL | Exit | ACCELRYS INC | $0 | – | -313,204 | -100.0% | -2.53% | – |
| 5100PS | Exit | VOLCANO CORPORATION | $0 | – | -151,638 | -100.0% | -2.81% | – |
| Exit | AKORN INC | $0 | – | -172,275 | -100.0% | -3.60% | – | |
| TEAR | Exit | TEARLAB CORP | $0 | – | -508,833 | -100.0% | -4.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.